| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 821 | 6.369 | 24.877 | 37.578 | 36.340 | 40.011 | 67.818 | 61.619 | 51.288 | 41.222 |
| Total Income - EUR | 821 | 6.369 | 24.878 | 47.923 | 54.057 | 46.044 | 87.444 | 62.073 | 89.806 | 52.285 |
| Total Expenses - EUR | 1.166 | 7.325 | 11.860 | 37.049 | 47.259 | 49.623 | 56.442 | 62.490 | 91.932 | 55.671 |
| Gross Profit/Loss - EUR | -345 | -956 | 13.018 | 10.874 | 6.798 | -3.579 | 31.001 | -418 | -2.126 | -3.386 |
| Net Profit/Loss - EUR | -370 | -1.147 | 12.272 | 10.042 | 6.179 | -3.846 | 29.085 | -1.684 | -2.126 | -3.386 |
| Employees | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Nucleus Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.074 | 4.509 | 2.955 | 4.733 | 22.210 | 12.787 | 11.364 | 8.029 | 32.491 | 25.152 |
| Current Assets | 60 | 1.745 | 8.595 | 17.434 | 24.742 | 10.642 | 41.173 | 42.831 | 16.452 | 19.523 |
| Inventories | 0 | 0 | 0 | 200 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 1.559 | 3.859 | 1.747 | 3.121 | 726 | 9 | 2 | 41 | 1.110 |
| Cash | 60 | 186 | 4.735 | 15.487 | 21.621 | 9.917 | 41.165 | 42.829 | 16.411 | 18.412 |
| Shareholders Funds | -325 | -1.469 | 10.828 | 20.671 | 26.450 | 22.103 | 50.697 | 49.171 | 46.895 | 43.247 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.459 | 7.723 | 722 | 1.496 | 20.502 | 1.326 | 1.840 | 1.689 | 2.047 | 1.429 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8692 - 8692" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Nucleus Med S.r.l.